Ketamine Renaudin

Ketamine, the active ingredient in Ketamine Renaudin, is a dissociative anesthetic presented as a sterile injectable solution for intramuscular, intravenous use. It is employed to induce and maintain anesthesia and to provide analgesia for acute pain, and it is sometimes used off‑label for treatment‑resistant depression.

GNH USA supplies Ketamine Renaudin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ketamine is a dissociative anesthetic used across several clinical pathways. - Induction and maintenance of anesthesia: provides rapid, controllable dissociative anesthesia for surgical procedures. - Analgesia for acute pain: delivers potent analgesic effect in peri‑operative and trauma settings. - Off‑label use for treatment‑resistant depression: may be administered under specialist supervision to alleviate depressive symptoms.

Ketamine can produce a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Hypertension: transient increase in blood pressure. - Tachycardia: elevated heart rate during and shortly after administration. - Nausea or vomiting: gastrointestinal upset common after induction. - Emergence phenomena: vivid dreams, hallucinations, or dysphoria during recovery.

Serious or Rare Side Effects: - Respiratory depression: reduced breathing effort requiring airway support. - Laryngospasm: sudden vocal cord closure that may obstruct airway. - Neurotoxicity: rare reports of cortical damage with prolonged high‑dose exposure.

Ketamine requires careful patient assessment and monitoring. - Cardiovascular assessment: evaluate baseline blood pressure and heart rate before use. - Psychiatric history: consider risk of emergence phenomena in patients with psychosis. - Drug interactions: avoid concurrent use with other NMDA antagonists or potent CNS depressants. - Pregnancy and lactation: use only if benefits outweigh potential risks, as safety data are limited. - Storage: Store at below 25°C: keep in original container, protect from light and moisture.

Ketamine may interact with several drug classes, necessitating vigilance.

Major Interactions (Avoid): - Other NMDA antagonists (e.g., dextromethorphan): additive CNS effects. - Central nervous system depressants (e.g., benzodiazepines, opioids): heightened respiratory depression.

Moderate Interactions (Monitor Closely): - Sympathomimetic agents (e.g., epinephrine): may exacerbate hypertension. - MAO inhibitors: potential for unpredictable hemodynamic changes. - Anticholinergic drugs: may increase risk of urinary retention.